Lisette M van Leeuwen1, Lidwine B Mokkink2, Christian P Kamm3,4, Vincent de Groot5, Pauline van den Berg6, Raymond W J G Ostelo2,7, Bernard M J Uitdehaag4. 1. a Department of Otolaryngology - Head and Neck Surgery, Section Ear & Hearing , EMGO Institute for Health and Care Research, VU University Medical Center , Amsterdam , The Netherlands. 2. b Department of Epidemiology and Biostatistics, EMGO institute for Health and Care Research , VU University Medical Center , Amsterdam , The Netherlands. 3. c Department of Neurology, Inselspital , Bern University Hospital, University of Bern , Bern , Switzerland. 4. d Department of Neurology , VU University Medical Center , Amsterdam , The Netherlands. 5. e Department of Rehabilitation Medicine , VU University Medical Center , Amsterdam , The Netherlands. 6. f Nieuw Unicum Zandvoort , Zandvoort , The Netherlands. 7. g Department of Health Sciences, Faculty of Earth and Life Science , EMGO Institute for Health and Care Research, VU University Medical Center , Amsterdam , The Netherlands.
Abstract
PURPOSE: The construct validity, test-retest reliability, and measurement error of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) were examined. Additionally, the influence of administration-method on reliability and measurement error was investigated. METHOD: 112 Dutch adult MS-patients from an academic- and a residential care-facility participated. Questionnaires were administered on paper, online or as interview, and patients performed several performance tests. Construct validity was assessed by testing pre-defined hypotheses. Reliability was assessed using Intraclass Correlation Coefficients (ICCs), Standard Error of Measurements (SEMs) and Smallest Detectable Changes (SDCs). RESULTS: For construct validity (N = 105) 9 of 13 hypotheses were confirmed (69%). As expected, the AMSQ showed moderate to strong relationships with the instruments measuring similar constructs. The test-retest reliability coefficient was 0.96 (95% Confidence Interval 0.94-0.97); SEM was 6.3 (6.3% of scale range); SDC was 17.5 (on a sale from 0 to 100). Different administration-methods showed good reliability (ICC 0.88-0.94) and small standard errors (SEM 5.6-7.2). CONCLUSION: The AMSQ shows satisfying results for validity and excellent reliability; allowing for proper use in research. Due to a large SDC value, caution is needed when using the AMSQ in individual patient care. Further research should determine whether the SDC is smaller than the minimal important change. Implications for Rehabilitation The Arm Function in Multiple Sclerosis Questionnaire (AMSQ) measures activity limitations due to hand and arm functioning in patients with Multiple Sclerosis (MS). Results of this study confirm adequate validity and reliability of the AMSQ in patient with MS. The equivalence of scores from online, paper or interview administration is supported. A change score of ≥18 points on the scale of the AMSQ (on a scale 0-100) needs to occur to be certain a change beyond measurement error has occurred in an individual patient.
PURPOSE: The construct validity, test-retest reliability, and measurement error of the Arm Function in Multiple Sclerosis Questionnaire (AMSQ) were examined. Additionally, the influence of administration-method on reliability and measurement error was investigated. METHOD: 112 Dutch adult MS-patients from an academic- and a residential care-facility participated. Questionnaires were administered on paper, online or as interview, and patients performed several performance tests. Construct validity was assessed by testing pre-defined hypotheses. Reliability was assessed using Intraclass Correlation Coefficients (ICCs), Standard Error of Measurements (SEMs) and Smallest Detectable Changes (SDCs). RESULTS: For construct validity (N = 105) 9 of 13 hypotheses were confirmed (69%). As expected, the AMSQ showed moderate to strong relationships with the instruments measuring similar constructs. The test-retest reliability coefficient was 0.96 (95% Confidence Interval 0.94-0.97); SEM was 6.3 (6.3% of scale range); SDC was 17.5 (on a sale from 0 to 100). Different administration-methods showed good reliability (ICC 0.88-0.94) and small standard errors (SEM 5.6-7.2). CONCLUSION: The AMSQ shows satisfying results for validity and excellent reliability; allowing for proper use in research. Due to a large SDC value, caution is needed when using the AMSQ in individual patient care. Further research should determine whether the SDC is smaller than the minimal important change. Implications for Rehabilitation The Arm Function in Multiple Sclerosis Questionnaire (AMSQ) measures activity limitations due to hand and arm functioning in patients with Multiple Sclerosis (MS). Results of this study confirm adequate validity and reliability of the AMSQ in patient with MS. The equivalence of scores from online, paper or interview administration is supported. A change score of ≥18 points on the scale of the AMSQ (on a scale 0-100) needs to occur to be certain a change beyond measurement error has occurred in an individual patient.
Entities:
Keywords:
AMSQ; Arm function in multiple sclerosis questionnaire; activity limitations; hypotheses testing; smallest detectable change; standard error of measurement; test–retest reliability
Authors: Michiel Aj Luijten; Iris Eekhout; Marie D'Hooghe; Bernard Mj Uitdehaag; Lidwine B Mokkink Journal: Mult Scler Date: 2018-11-09 Impact factor: 6.312
Authors: Caspar Ep van Munster; Levent Kaya; Morgan Obura; Nynke F Kalkers; Bernard Mj Uitdehaag Journal: Mult Scler Date: 2019-01-18 Impact factor: 6.312
Authors: Caspar Ep van Munster; Marcus D'Souza; Saskia Steinheimer; Christian P Kamm; Jessica Burggraaff; Manuela Diederich; Kristina Kravalis; Jonas Dorn; Lorcan Walsh; Frank Dahlke; Ludwig Kappos; Bernard Mj Uitdehaag Journal: Mult Scler Date: 2018-08-31 Impact factor: 6.312